R&D / Overview
HRA Pharma's focus is on developing leading products that fulfill unmet medical needs. The company combines its medical, business and regulatory expertise with its corporate mission to rapidly and efficiently lead product candidates through clinical development.
Each year HRA Pharma reinvests some 15 to 25% of sales in R&D. Currently we are developing innovative medicines and products for reproductive health and endocrine diseases. In addition we are continually evaluating innovative technologies and approaches in order to bring new products to market.